BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

Search

Fresenius SE & Co KGaA

Fechado

SetorSaúde

39.86 -0.2

Visão Geral

Variação de preço das ações

24h

Atual

Mín

39.7

Máximo

40.25

Indicadores-chave

By Trading Economics

Rendimento

-48M

271M

Vendas

264M

5.6B

P/E

Médio do Setor

24.381

57.333

Margem de lucro

4.813

Funcionários

176,486

EBITDA

-33M

724M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+17.39% upside

Dividendos

By Dow Jones

Próximos Ganhos

7 de mai. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1.1B

22B

Abertura anterior

40.06

Fecho anterior

39.86

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Fresenius SE & Co KGaA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de fev. de 2025, 13:37 UTC

Conversa de Mercado

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

5 de jun. de 2024, 12:18 UTC

Conversa de Mercado

Fresenius Helios Guidance Lift Should Drive Consensus Upgrades -- Market Talk

Comparação entre Pares

Variação de preço

Fresenius SE & Co KGaA Previsão

Preço-alvo

By TipRanks

17.39% parte superior

Previsão para 12 meses

Média 46.78 EUR  17.39%

Máximo 56.9 EUR

Mínimo 42 EUR

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para Fresenius SE & Co KGaA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

13 ratings

11

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

39.5 / 39.92Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bullish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.